Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says
The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.
It marked another increase after the prior month's annual gain of 6%, and the fastest rate of price growth since...
Walmart said clinics are not a sustainable business model due to a challenging reimbursement environment for primary care and increasing...
Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in...
One of the largest entertainment operators in the country, Dave & Buster's, will allow its loyalty customers to compete against...
The restaurant company is planning to spend $2.2 billion to revive Burger King's U.S. business.
The nation's largest grocer sees room to build on its inflation-fueled grocery gains.
Average Rating